109520 ⎘
Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from adult fibroblasts
FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS
#2GENE CORRECTION INDUCED NEURAL STEM CELLS USING HUNTINGTIN GENE-SPECIFIC GUIDE RNA, AND CELL THERAPEUTIC AGENT USING THE SAME
#3PERSONALIZED MUC1-C INDUCED PLURIPOTENT STEM CELL AND DENDRITIC CELL BASED VACCINES
#4CELL CULTURE PLATFORM FOR SINGLE CELL SORTING AND ENHANCED REPROGRAMMING OF IPSCS
#5PRODUCTION METHOD FOR INDUCED PLURIPOTENT STEM CELLS
#6SYSTEMS FOR STEM CELL PROGRAMMING AND METHODS THEREOF
#7METHOD FOR IDENTIFYING EFFECTIVE TREATMENTS AGAINST NEURODEGENERATIVE DISORDERS
#8SYSTEMS AND METHODS FOR GROWING CELLS IN VITRO
#9METHOD FOR CONVERTING HUMAN SOMATIC CELLS INTO PROLIFERATIVE NEURAL STEM CELLS
#10DIFFERENTIATION INDUCER CONTAINING NUCLEUS PULPOSUS PROGENITOR CELL MASTER REGULATOR TRANSCRIPTION FACTORS, METHOD FOR PRODUCING INDUCED NUCLEUS PULPOSUS PROGENITOR CELLS, AND USE OF INDUCED NUCLEUS PULPOSUS PROGENITOR CELLS
#11CELLS DIFFERENTIATED FROM IMMUNOENGINEERED PLURIPOTENT CELLS
#12MAKING AND USING IN VITRO SYNTHESIZED ssRNA FOR INTRODUCING INTO MAMMALIAN CELLS TO INDUCE A BIOLOGICAL OR BIOCHEMICAL EFFECT
#13METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELL, NUCLEIC ACID INTRODUCTION CARRIER AND KIT
#14METHODS OF MAKING INDUCED PLURIPOTENT STEM CELLS
#15SYSTEMS
#16METHODS AND SYSTEMS FOR DIFFERENTIATION OF CELLS USING OPTOGENETICS
#17A COMBINED HUMAN GASTRULOID MODEL OF CARDIOGENESIS AND NEUROGENESIS
#18INDUCTION OF PLURIPOTENT CELLS
#19METHOD OF MANUFACTURING AUTOLOGOUS CARDIAC LINEAGE CELLS
#20SYSTEMS AND METHODS FOR GROWING CELLS IN VITRO
#21AAV-BASED MODULATION OF GBA1 AND RELATED COMPOSITIONS AND USES THEREOF
#22Composition for inducing direct reprogramming comprising self-assembled RNA construct
#23TRANSDIFFERENTIATION OF NON-HAIR FOLLICLE STEM CELLS TO NON-AUDITORY INDUCED HAIR FOLLICLE STEM CELLS
#24ENGINEERED EXRACELLULAR VESICLES WITH TAILORED TROPISM
#25miRNA REPROGRAMMING OF SMOOTH MUSCLE CELLS INTO ENDOTHELIAL CELLS
#26METHODS AND COMPOSITIONS FOR BAT IPSC PREPARATION AND USE
#27METHODS FOR THE TEMPORAL REGULATION OF REPROGRAMMING FACTORS IN MAMMALIAN CELLS
#28Screening Method Using Brown Adipocytes
#29Method for Producing Cardiomyocytes by Means of Reprogramming
#30Method for Treating Ilk Signaling Pathway Related Diseases Using Exosome Derived from Mesenchymal Stem Cells, and Pharmaceutical Composition
#31Live Virus Vaccine Injury Risk
#32Reprogramming Somatic Cells on Microcarriers
#33THREE-DIMENSIONAL DIRECT NEURONAL REPROGRAMMING TO MODEL ALZHEIMER'S DISEASE IN HUMAN NEURONS
#34METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#35METHOD OF REPROGRAMMING CELLS
#36COMPOSITIONS AND METHODS FOR THE GENERATION OF NEURONS AND USES THEREOF
#37CELL CULTURE SUPPLEMENT FOR PRODUCING STEM CELLS, AND METHOD FOR PRODUCING STEM CELLS
#38METHODS AND COMPOSITIONS FOR CELL REPROGRAMMING
#39METHODS FOR REPROGRAMMING SOMATIC CELLS
#40niPSCs DERIVED FROM SOMATIC CELLS
#41CELL CONVERSION
#42TREATMENT OF CANAVAN DISEASE
#43CHEMICAL REPROGRAMMING OF HUMAN SOMATIC CELLS INTO PLURIPOTENT CELLS
#44ENGINEERED IMMUNE CELL THERAPIES
#45METHODS AND COMPOSITIONS FOR MANUFACTURING EXTRACELLULAR MATRIX
#46Synergistic Genome-Nonintegrating Reprogramming by Micrornas and Transcription Factors
#47METHODS TO CONVERT SOMATIC HUMAN CELL TO A TOTIPOTENCY-LIKE STATE WITH ENGINEERED SOX17
#48METHOD FOR PREPARING BROWN ADIPOCYTE
#49Method for Producing Naive Human IPS Cells From Somatic Cells
#50COMPOSITIONS, CONSTRUCTS AND VECTORS FOR CELL REPROGRAMMING
#51Method for Reprogramming Cell
#52Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells
#53METHOD FOR DIRECT REPROGRAMMING FROM SOMATIC CELLS INTO PANCREATIC BETA CELLS BY USING MICRORNA, AND DIFFERENTIATION COMPOSITION
#54Composition for Inducing Direct Cross Differentiation of Somatic Cell into Motor Neuron, and Method for Using Same
#55METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#56A CHEMICAL COCKTAIL DRIVING EXPANSION OF MYOGENIC STEM CELLS
#57CELL REPROGRAMMING
#58METHOD FOR IN VITRO REPROGRAMMING OF FIBROBLASTS INTO SERTOLI CELLS AND APPLICATION THEREOF
#59FIBROBLAST BASED THERAPY FOR TREATMENT OF PARKINSON'S DISEASE
#60METHOD FOR FIBROBLAST REJUVENATION BY MECHANICAL REPROGRAMMING AND REDIFFERENTIATION
#61METHODS FOR REPROGRAMMING CELLS AND USES THEREOF
#62SCALING UP MYOGENIC TISSUE: LATE PASSAGE MYOGENICITY
#63FIBROBLASTS AS A REGENERATIVE CELLULAR SOURCE FOR THE TREATMENT OF BLINDNESS
#64SELF-ASSEMBLING MULTICELLULAR BODIES AND METHODS OF PRODUCING A THREE-DIMENSIONAL BIOLOGICAL STRUCTURE USING THE SAME
#65TREATMENT OF OVARIAN FAILURE USING REGENERATIVE CELLS
#66DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION
#67Reagents and Methods for Alzheimer's Disease and CoMorbidities Thereof
#68Composition for Medium
#69METHOD FOR CULTURING FACTOR-INTRODUCED CELLS
#70Method for Producing Brown Adipocytes
#71GENETICALLY CORRECTED CELLS FOR THERAPEUTIC USE
#72DIRECT REPROGRAMMING OF SOMATIC CELLS INTO MYOGENIC CELLS
#73MUTANT KLF PROTEIN, AND METHOD FOR PRODUCING INDUCED PLURIPOTENT STEM CELLS
#74Lineage Reprogramming to Induced Cardiac Progenitor Cells (iCPC) By Defined Factors
#75COMPOSITION FOR ENHANCING REPROGRAMMING EFFICIENCY FROM SOMATIC CELL TO INDUCED PLURIPOTENT STEM CELL, COMPRISING MTOR ACTIVATOR, AND METHOD FOR ENHANCING REPROGRAMMING EFFICIENCY BY USING SAME
#76METHOD AND COMPOSITION FOR INDUCING HUMAN PLURIPOTENT STEM CELLS
#77PRODUCTION METHOD FOR INDUCED DOPAMINERGIC NEURONAL PROGENITORS, USING DIRECT REPROGRAMMING
#78METHOD FOR PRODUCING PANCREATIC ENDOCRINE CELLS, AND TRANSDIFFERENTIATION AGENT
#79COMPOSITION AND METHOD FOR INDUCING DIFFERENTIATION INTO MYELOID CELLS, AND USE THEREOF
#80METHODS AND COMPOSITIONS FOR REPROGRAMMING CELLS
#81Methods for reprogramming somatic cells
#82METHODS OF REPROGRAMMING A CELL
#83METHODS FOR PRODUCING NEURAL CELLS
#84Methods for Reprogramming Cells
#85METHOD FOR CULTURING MYOGENIC CELLS, CULTURES OBTAINED THEREFROM, SCREENING METHODS, AND CELL CULTURE MEDIUM
#86INDUCTION OF TUMOR VASCULAR NECROSIS UTILIZING FIBROBLASTS
#87METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELL WITHOUT USING HYDROGEL
#88METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS BY REPROGRAMMING SOMATIC CELLS
#89COMPOSITIONS FOR REPROGRAMMING CELLS INTO DENDRITIC CELLS OR ANTIGEN PRESENTING CELLS, METHODS AND USES THEREOF
#90Reprogramming progenitor compositions and methods of use thereof
#91FIBROBLAST GENERATED PATIENT-SPECIFIC VACCINES
#92UROTHELIAL CELL INDUCTION AGENT AND METHOD FOR INDUCING UROTHELIAL CELLS
#93DIFFERENTIATION INDUCER CONTAINING NUCLEUS PULPOSUS PROGENITOR CELL MASTER REGULATOR TRANSCRIPTION FACTORS, METHOD FOR PRODUCING INDUCED NUCLEUS PULPOSUS PROGENITOR CELLS, AND USE OF INDUCED NUCLEUS PULPOSUS PROGENITOR CELLS
#94PRODUCING ASTROCYTES USING SMALL MOLECULES
#95MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
#96Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
#97Chemical reprogramming to generate neuronal cells
#98FIBROBLAST CELL THERAPY FOR TREATMENT OF OSTEOPOROSIS
#99PRODUCTION METHOD AND KIT OF INDUCED PLURIPOTENT STEM CELLS
#100USE OF PCBP1 TO GENERATE INDUCED PLURIPOTENT STEM CELLS WHILE INHIBITING ONCOGENESIS
#101PLATELET-RICH PLASMA COMPOSITIONS AND METHODS OF PREPARATION
#102Multicistronic miRNA delivery for cardiac reprogramming
#103METHOD FOR MANUFACTURING CELL POPULATION INCLUDING LIVER PRECURSOR CELLS
#104INCREASING GENOME STABILITY AND REPROGRAMMING EFFICIENCY OF INDUCED PLURIPOTENT STEM CELLS
#105CULTURE MEDIUM FOR MAMMALIAN EXPANDED POTENTIAL STEM CELLS, COMPOSITION, AND METHODS THEREOF
#106PANCREATIC ENDOCRINE CELLS, METHOD FOR PRODUCING SAME, AND TRANSDIFFERENTIATION AGENT
#107NOVEL REPROGRAMMING METHOD
#108METHODS FOR REGULATING POTENCY OF PLURIPOTENT STEM CELLS AND APPLICATIONS THEREOF
#109SYSTEMIC SCLEROSIS DISEASE MODEL AND USE THEREOF
#110DRUG DISCOVERY AND EARLY DISEASE IDENTIFICATION PLATFORM USING ELECTRONIC HEALTH RECORDS, GENETICS AND STEM CELLS
#111METHOD FOR PRODUCING INSULIN-PRODUCING CELLS, AND COMPOSITION
#112Methods for reprograming non-pluripotent cells into pluripotent stem cells
#113Induction of pluripotent cells
#114CELLS DIFFERENTIATED FROM IMMUNOENGINEERED PLURIPOTENT CELLS
#115MATERIALS AND METHODS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTAL TEMPORAL LOBULAR DEGENERATION
#116METHOD TO GENERATE INDUCED OLIGODENDROCYTE-LINEAGE CELLS AND TREATMENT USING SUCH CELLS
#117PRODUCTION METHOD FOR NEURON-LIKE CELLS
#118Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors
#119METHOD FOR PRODUCING PANCREATIC ENDOCRINE CELLS
#120Cell induction method
#121REPROGRAMMING OF CELLS TO A NEW FATE
#122Reprogramming vectors
#123REPROGRAMMING FIBROBLASTS TO RETINAL CELLS
#124SYSTEMS AND METHODS FOR GROWING CELLS IN VITRO
#125Induced pluripotent stem cells (IPSCS) and applications thereof
#126GENERATION OF HUMAN iPS CELLS BY A SYNTHETIC SELF-REPLICATIVE RNA
#127Production and Therapeutic Uses of Epinul Cells and Differentiated Cells Derived Therefrom
#128CELL CULTURE PLATFORM FOR SINGLE CELL SORTING AND ENHANCED REPROGRAMMING OF IPSCS
#129Method for producing insulin-producing cells
#130PLACENTA-DERIVED CELL-CONDITIONED MEDIUM FOR INDUCING DEDIFFERENTIATION INTO INDUCED PLURIPOTENT STEM CELLS FROM SOMATIC CELLS AND METHOD FOR INDUCING DEDIFFERENTIATION USING THE SAME
#131METHOD FOR IDENTIFYING EFFECTIVE TREATMENTS AGAINST NEURODEGENERATIVE DISORDERS
#132Method for inducing oligodendrocyte precursor cells from OCT4-induced human somatic cells through direct reprogramming
#133METHOD FOR REPROGRAMMING SOMATIC CELLS
#134Light mounting systems and methods
#135SELF REPLICATING RNA FOR INDUCING SOMATIC DIFFERENTIATION OF UNMODIFIED ADULT STEM CELLS
#136BROWN FAT CELLS AND METHOD FOR PREPARING SAME
#137COMPOSITIONS AND METHODS FOR THE GENERATION OF NEURONS AND USES THEREOF
#138Human iPSC-based drug testing platform for muscular dystrophy
#139Method for producing cardiomyocytes
#140Direct reprogramming of cells to cardiac myocyte fate
#141Agent for accelerating maturation or aging of cells
#142Protein-induced pluripotent cell technology and uses thereof
#143RNA replicon for reprogramming somatic cells
#144Method for generating induced pluripotent stem cells from fibroblast cells
#145Small Molecule-Induced Method for Directly Reprogramming Human Fibroblasts into Liver Cells
#146Methods for reprogramming cells and uses thereof
#147Methods and compositions for repair of cartilage using an in vivo bioreactor
#148METHOD FOR THE IN VITRO PREPARATION OF DERMAL PAPILLA AND HAIR FOLLICLE EQUIVALENTS
#149COMPOSITION AND KIT FOR DIFFERENTIATING CANCER ASSOCIATED FIBROBLASTS INTO MACROPHAGES, AND METHOD OF USING THE SAME
#150Methods for reprogramming somatic cells
#151METHODS AND SYSTEMS FOR RECONSTRUCTION OF DEVELOPMENTAL LANDSCAPES BY OPTIMAL TRANSPORT ANALYSIS
#152CELL REPROGRAMMING TO CARDIOMYOCYTES
#153Avian induced pluripotent stem cells and their use
#154METHOD OF NUCLEAR REPROGRAMMING
#155CELL REPROGRAMMING METHODS FOR PRODUCING CHONDROCYTES
#156NOVEL METHODS FOR THE GENERATION AND USE OF HUMAN INDUCED NEURAL BORDER STEM CELLS
#157Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same
#158METHOD FOR EFFICIENT GENERATION OF NEURONS FROM NON-NEURONAL CELLS
#159Compositions and methods for reprogramming somatic cells into induced vasculogenic cells
#160REPROSOMES, AS EXOSOMES CAPABLE OF INDUCING REPROGRAMMING OF CELLS AND PREPARATION METHOD THEREOF
#161Method for rejuvenating cells
#162SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#163SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#164SYSTEMS
#165SYSTEMS AND METHODS FOR GROWING CELLS IN VITRO
#166SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#167A MODIFIED CELL CULTURE MEDIUM AND USES THEREOF
#168Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof
#169Compositions comprising glucosylated hydroxymethylated bases
#170PLATELET-RICH PLASMA COMPOSITIONS AND METHODS OF PREPARATION
#171Reprogramming of cells to a new fate
#172Method for inducing differentiated cell into Mesenchymal Stem Cell, and combinations of regulatory targets thereof
#173Skeletal muscle cells and method for inducing same
#174Generation of human iPS cells by a synthetic self-replicative RNA
#175Method of generating mesenchymal stem cells and uses thereof
#176MEANS AND METHODS FOR THE GENERATION OF OLIGODENDROCYTES
#177Making and using in vitro-synthesized ssRNA for introducing into mammalian cells to induce a biological or biochemical effect
#178TREATMENT OF CANAVAN DISEASE
#179Methods for identifying hydroxylated bases
#180Method for inducing oligodendrocyte precursor cells from Oct4-induced human somatic cells through direct reprogramming
#181METHODS AND COMPOSITIONS RELATED TO INDUCED SENSORY NEURONS
#182Method for cellular RNA expression
#183Materials and methods for treatment of hemoglobinopathies
#184Selective oxidation of 5-methylcytosine by TET-family proteins
#185Method for producing somatic cell, somatic cell, and composition
#186Human induced pluripotent stem cells for high efficiency genetic engineering
#187Compositions of Ascorbic Acid and Bone Morphogenetic Protein 4 (BMP-4) for Cell Growth and Uses Related Thereto
#188Producing astrocytes using small molecules
#189Protein-induced pluripotent cell technology and uses thereof
#190Combinational use of mechanical manipulation and programin derivatives to increase Oct4, Sox2, Nanog or c-Myc expression in fibroblasts
#191Method for culturing myogenic cells, cultures obtained therefrom, screening methods, and cell culture medium
#192Cellular Reprogramming Utilizing mRNA
#193Pancreatic endocrine cells, method for producing same, and transdifferentiation agent
#194METHODS FOR ENGINEERING NON-NEURONAL CELLS INTO NEURONS AND USING NEWLY ENGINEERED NEURONS TO TREAT NEURODEGENERATIVE DISEASES
#195Cells for Therapy of the Heart
#196Methods for reprogramming cells and uses thereof
#197Methods for reprogramming somatic cells
#198Method of producing renal cells from differentiated cells
#199METHOD FOR DIRECTLY PRODUCING CARDIAC PRECURSOR CELL OR MYOCARDIAL CELL FROM FIBROBLAST
#200Methods for distinguishing 5-hydroxymethylcytosine from 5-methylcytosine
#201Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA
#202Method for direct transdifferentiation reprogramming into neurons using electromagnetic-induced metal nanoparticles
#203SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#204SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#205Selective oxidation of 5-methylcytosine by TET-family proteins
#206METHODS FOR GENERATING CARDIOMYOCYTES
#207REPROGRAMMING CARDIOMYOCYTES WITH ONE TRANSCRIPTION FACTOR
#208Methods and compositions for manufacturing extracellular matrix
#209Methods for reprogramming cells and uses thereof
#210Reprogramming-based models of neurodevelopmental disorders and uses thereof
#211Compositions and methods for the generation of melanocytes through direct reprogramming
#212Methods and compositions for reprogramming cells
#213METHOD FOR PREPARING BROWN ADIPOCYTE
#214Methods and compositions for reprogramming cells
#215Direct reprogramming of cells to cardiac myocyte fate
#216METHODS OF CONTROLLING CELL FATE AND CONSEQUENCES FOR DISEASE
#217Methods for Cardiac Differentiation of Human Induced Pluripotent Stem Cells
#218Methods and compositions for repair of cartilage using an in vivo bioreactor
#219METHOD FOR REJUVENATING CELLS
#220Method for producing pancreatic endocrine cells, and transdifferentiation agent
#221ASTROCYTE DIFFERENTIATION PROTOCOL
#222Kit and method for producing induced embryonic neural progenitors
#223Detection of 5-hydroxymethylcytosine by glycosylation
#224Means and methods for generating midbrain organoids
#225Labeling hydroxymethylated residues
#226Compostition for reprogramming cells
#227AGE-MODIFIED CELLS AND METHODS FOR MAKING AGE-MODIFIED CELLS
#228Generation of human iPS cells by a synthetic self-replicative RNA
#229Compositions and methods for reprogramming non-neuronal cells into neuron-like cells
#230COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS
#231Induction of pluripotent cells
#232METHOD OF ENHANCING SOMATIC CELL REPROGRAMMING WITH THE ACETYLLYSINE READER BRD3R
#233Cell having ability to form stratified epithelial tissue, and method for producing same
#234Method for correcting a genetic sequence
#235PRODUCTION AND THERAPEUTIC USES OF EPINUL PLURIPOTENT CELLS AND DIFFERENTIATED CELLS DERIVED THEREFROM
#236Protein-induced pluripotent cell technology and uses thereof
#237Kits and materials for implantable collagen devices
#238Selective oxidation of 5-methylcytosine by TET-family proteins
#239METHODS AND MATERIALS FOR OBTAINING INDUCED PLURIPOTENT STEM CELLS
#240Direct conversion method of somatic cell into Hepatic stem cell, hepatic cell, or cholangiocyte
#241Delivery vehicles for stem cells and uses thereof
#242DIRECT CONVERSION OF CELLS TO CELLS OF OTHER LINEAGES
#243Cell fate conversion of differentiated somatic cells into glial cells
#244Reprogramming progenitor compositions and methods of use therefore
#245Reprogramming method for producing induced pluripotent stem cells (iPSC)
#246Direct conversion method of human fibroblasts into neural stem cells using small molecules
#247Method for producing nervous system cells
#248CHEMICAL APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS
#249DIRECT CONVERSION OF CELLS TO CELLS OF OTHER LINEAGES
#250Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
#251Method for inducing cell reprogramming, and method for producing pluripotent cells
#252CD11 B[low] MACROPHAGES AND CONDITIONED MEDIA THEREOF FOR TREATING CANCER AND/OR FIBROSIS
#253Device and method for inducing pluripotent cells using energy
#254Artificial three-dimensional microenvironment niche culture and methods of using the same
#255Method for preparing induced pluripotent stem cells using synthetic peptide
#256INDUCED PLURIPOTENT STEM CELLS
#257Methods for reprogramming somatic cells
#258Synthetic peptide and use thereof
#259Method for generating neuronal and muscular cells
#260Selective oxidation of 5-methylcytosine by TET-family proteins
#261Methods for reprograming non-hepatocyte cells into hepatocyte cells
#262ENHANCED REPROGRAMMING TO IPS CELLS
#263Pancreatic endocrine cells, method for producing same, and transdifferentiation agent
#264Selective oxidation of 5-methylcytosine by TET-family proteins
#265Methods of controlling cell fate and consequences for disease
#266SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#267Method and composition for inducing human pluripotent stem cells
#268Method and composition for inducing human pluripotent stem cells
#269Reprogramming of cells to a new fate
#270CELL PROGRAMMING
#271Selective oxidation of 5-methylcytosine by TET-family proteins
#272METHOD FOR PREPARING INDUCED PLURIPOTENT STEM CELLS
#273Composition for inducing direct transdifferentiation of somatic cell into vascular progenitor cell, and use thereof
#274Platelet-rich plasma compositions and methods of preparation
#275Method for inducing pluripotent stem cells and pluripotent stem cells prepared by said method
#276MEGAKARYOCYTE AND PLATELET PRODUCTION FROM STEM CELLS
#277Electrospun electroactive polymers for regenerative medicine applications
#278Pluripotent cell lines and methods of use thereof
#279Culture medium for pluripotent stem cells
#280Methods for reprogramming cells and uses thereof
#281Methods for reprogramming cells and uses thereof
#282Methods for reprogramming cells and uses thereof
#283Method for producing neural stem cells using synthetic peptide
#284Combined chemical and genetic approaches for generation of induced pluripotent stem cells
#285Methods of differentiating preadipocytes and uses thereof
#286Generating hepatocytes
#287Composition for inducing direct transdifferentiation into oligodendrocyte progenitor cells from somatic cells and use thereof
#288CONVERSION OF SOMATIC CELLS INTO NOCICEPTORS, AND METHODS OF USE THEREOF
#289Method for preparing osteoblasts and osteoblast inducer
#290Methods for reprogramming cells and uses thereof
#291Trans-differentiation of differentiation cells
#292Chemical approaches for generation of induced pluripotent stem cells
#293METHOD FOR PRODUCING INDUCED PLURIPOTENT CELLS
#294CONVERSION OF SOMATIC CELLS TO INDUCED REPROGRAMMED NEURAL STEM CELLS (IRNSCS)
#295Small molecule based conversion of somatic cells into neural crest cells
#296Population of isolated chicken cells reprogrammed from somatic cells
#297Methods and compositions related to induced sensory neurons
#298Methods for making induced pluripotent stem cells
#299Method for Producing Induced Pluripotent Stem Cells
#300Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors